Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0025 | 0.0195 | 0.0195 |
Toxoplasma gondii | cytidine and deoxycytidylate deaminase zinc-binding region domain-containing protein | 0.0122 | 1 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0025 | 0.0195 | 0.0195 |
Onchocerca volvulus | 0.0122 | 1 | 1 | |
Mycobacterium tuberculosis | Probable cytidine deaminase Cdd (cytidine aminohydrolase) (cytidine nucleoside deaminase) | 0.0122 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0023 | 0 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0086 | 0.6312 | 0.6312 |
Mycobacterium leprae | PROBABLE CYTIDINE DEAMINASE CDD (CYTIDINE AMINOHYDROLASE) (CYTIDINE NUCLEOSIDE DEAMINASE) | 0.0122 | 1 | 0.5 |
Entamoeba histolytica | cytidine deaminase, putative | 0.0122 | 1 | 0.5 |
Leishmania major | cytidine deaminase-like protein | 0.0122 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0086 | 0.6312 | 1 |
Trichomonas vaginalis | cytidine deaminase, putative | 0.0122 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0025 | 0.0195 | 0.0195 |
Trypanosoma cruzi | cytidine deaminase-like protein, putative | 0.0122 | 1 | 1 |
Trypanosoma cruzi | cytidine deaminase-like protein | 0.0122 | 1 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0023 | 0 | 0.5 |
Mycobacterium ulcerans | cytidine deaminase | 0.0122 | 1 | 0.5 |
Onchocerca volvulus | 0.0122 | 1 | 1 | |
Echinococcus granulosus | cytidine deaminase | 0.0122 | 1 | 1 |
Echinococcus multilocularis | cytidine deaminase | 0.0122 | 1 | 1 |
Trypanosoma brucei | cytidine deaminase | 0.0122 | 1 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0025 | 0.0195 | 0.0195 |
Trichomonas vaginalis | cytidine deaminase, putative | 0.0122 | 1 | 1 |
Trypanosoma brucei | unspecified product | 0.0025 | 0.0195 | 0.0195 |
Giardia lamblia | Cytidine deaminase | 0.0122 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.